Determining failure after renal ablative therapy for renal cell carcinoma: false-negative and false-positive imaging findings.
Matin
Surena F
SF
Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. surmatin@mdanderson.org
D001707:Biopsy, Needle; D002292:Carcinoma, Renal Cell / Q000175:diagnosis* / Q000601:surgery*; D017115:Catheter Ablation / Q000009:adverse effects / Q000379:methods*; D015331:Cohort Studies; D003452:Cryosurgery / Q000009:adverse effects / Q000379:methods; D003952:Diagnostic Imaging / Q000379:methods*; D005188:False Negative Reactions; D005189:False Positive Reactions; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D007680:Kidney Neoplasms / Q000175:diagnosis* / Q000601:surgery*; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D019060:Minimally Invasive Surgical Procedures / Q000009:adverse effects / Q000379:methods; D011182:Postoperative Care / Q000379:methods; D012680:Sensitivity and Specificity; D014057:Tomography, X-Ray Computed / Q000379:methods; D017211:Treatment Failure